Laatste artikelen
-
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
-
Lingering Viral Spike Protein Found in the Lungs of Long COVID Patients
-
Scientists discover why some people still can’t taste food after COVID-19
-
BioVie shares Phase 2 bezisterim data for Long COVID treatment
-
Among Long COVID patients with the most fatigue, scores improved 8.93 points with BioVie’s drug vs 5.30 with placebo.
-
BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroups
-
Will the NIH Vaccine Injury Clinic Confront the Wuhan Spike Protein as Root Cause?
-
Electroacupuncture May Retune the Vagus Nerve to Calm Long COVID Inflammation
-
Long COVID Linked to Overactive Fat-Metabolizing Enzymes That Fail to Resolve Inflammation
-
Probiotic VSL#3 Eases Long COVID Fatigue in Randomized Trial
-
This week in science: sea monsters, long COVID patients' microbiome, elephant carcasses
-
Five studies map the tangled biology of Long COVID, from lungs to gut
-
Journal retracts, republishes paper on Long COVID treatment trial
-
Can brain surgery reverse Alzheimer's? Plus, new clues about long COVID and the future of health data
-
Dundee researchers link mouth and lung bacteria to long COVID
-
COVID-19 may damage the brain’s dopamine system, new study
-
COVID-19 May Leave a Lasting Mark on Allergy Risk, Massive Japanese Study Finds
